Proteomics and the blood–brain barrier: how recent findings help drug development - Archive ouverte HAL Access content directly
Journal Articles Expert Review of Proteomics Year : 2016

Proteomics and the blood–brain barrier: how recent findings help drug development

(1) , (1)
1

Abstract

The drug discovery and development processes are divided into different stages separated by milestones to indicate that significant progress has been made and that certain criteria for target validation, hits, leads and candidate drugs have been met. Proteomics is a promising approach for the identification of protein targets and biochemical pathways involved in disease process and thus plays an important role in several stages of the drug development. The blood-brain barrier is considered as a major bottleneck when trying to target new compounds to treat neurodegenerative diseases. Based on the survey of recent findings and with a projection on expected improvements, this report attempt to address how proteomics participates in drug development.
Not file

Dates and versions

hal-02510297 , version 1 (17-03-2020)

Identifiers

Cite

Yannis Karamanos, Gwënaël Pottiez. Proteomics and the blood–brain barrier: how recent findings help drug development. Expert Review of Proteomics, 2016, 13 (3), pp.251-258. ⟨10.1586/14789450.2016.1143780⟩. ⟨hal-02510297⟩

Collections

UNIV-ARTOIS LBHE
10 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More